IL191570A0 - Sulfamoyl sulfonate prodrugs - Google Patents

Sulfamoyl sulfonate prodrugs

Info

Publication number
IL191570A0
IL191570A0 IL191570A IL19157008A IL191570A0 IL 191570 A0 IL191570 A0 IL 191570A0 IL 191570 A IL191570 A IL 191570A IL 19157008 A IL19157008 A IL 19157008A IL 191570 A0 IL191570 A0 IL 191570A0
Authority
IL
Israel
Prior art keywords
sulfonate prodrugs
sulfamoyl
sulfamoyl sulfonate
prodrugs
sulfonate
Prior art date
Application number
IL191570A
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of IL191570A0 publication Critical patent/IL191570A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0072—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0038—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an androstane skeleton, including 18- or 19-substituted derivatives, 18-nor derivatives and also derivatives where position 17-beta is substituted by a carbon atom not directly bonded to a further carbon atom and not being part of an amide group

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
IL191570A 2005-11-30 2008-05-20 Sulfamoyl sulfonate prodrugs IL191570A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005057408A DE102005057408A1 (en) 2005-11-30 2005-11-30 New sulfamoylsulfonate prodrugs e.g. useful for protecting red blood cells from attack by parasites or for hormone replacement therapy, female fertility control or treating hormone-associated diseases
PCT/EP2006/011726 WO2007062874A2 (en) 2005-11-30 2006-11-27 Sulfamoyl sulfonate prodrugs

Publications (1)

Publication Number Publication Date
IL191570A0 true IL191570A0 (en) 2008-12-29

Family

ID=37983623

Family Applications (1)

Application Number Title Priority Date Filing Date
IL191570A IL191570A0 (en) 2005-11-30 2008-05-20 Sulfamoyl sulfonate prodrugs

Country Status (15)

Country Link
EP (1) EP1957513A2 (en)
JP (1) JP2009517424A (en)
KR (1) KR20080072956A (en)
CN (1) CN101316858A (en)
AU (1) AU2006319380A1 (en)
BR (1) BRPI0619253A2 (en)
CA (1) CA2632272A1 (en)
CR (1) CR10003A (en)
DE (1) DE102005057408A1 (en)
EA (1) EA200801306A1 (en)
EC (1) ECSP088489A (en)
IL (1) IL191570A0 (en)
NO (1) NO20082915L (en)
WO (1) WO2007062874A2 (en)
ZA (1) ZA200805659B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8293783B2 (en) * 2009-03-24 2012-10-23 National University Of Singapore Use of artemisinin derivatives for the treatment of asthma and chronic obstructive pulmonary disease (COPD)
CN101987104A (en) * 2009-08-05 2011-03-23 天津金耀集团有限公司 Ophthalmic composition of heteroaryl sulfamoyl carboxylic ester carbonic anhydrase inhibitor
CN101987101A (en) * 2009-08-05 2011-03-23 天津金耀集团有限公司 Anti-inflammatory eye composition with glucocorticoid aromatic sulfamoyl sulfonic acid ester as active ingredient

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10027887A1 (en) * 2000-05-31 2001-12-13 Jenapharm Gmbh Compounds with a sulfonamide group and pharmaceutical compositions containing these compounds
DE102004025966A1 (en) * 2004-05-21 2005-12-15 Schering Ag Estradiol prodrugs
DE102004025986A1 (en) * 2004-05-21 2005-12-15 Schering Ag Steroid prodrugs with androgenic effects
DE102004025985A1 (en) * 2004-05-21 2005-12-15 Schering Ag Estriol and estetrol prodrugs

Also Published As

Publication number Publication date
KR20080072956A (en) 2008-08-07
AU2006319380A1 (en) 2007-06-07
DE102005057408A1 (en) 2007-05-31
WO2007062874A3 (en) 2007-07-12
ZA200805659B (en) 2009-10-28
CN101316858A (en) 2008-12-03
JP2009517424A (en) 2009-04-30
EP1957513A2 (en) 2008-08-20
WO2007062874B1 (en) 2007-09-27
CR10003A (en) 2008-08-21
WO2007062874A2 (en) 2007-06-07
BRPI0619253A2 (en) 2011-09-27
ECSP088489A (en) 2008-06-30
EA200801306A1 (en) 2008-10-30
CA2632272A1 (en) 2007-06-07
NO20082915L (en) 2008-06-27

Similar Documents

Publication Publication Date Title
EP1932841A4 (en) Sulfonamide compound
PL1968612T3 (en) Dinucleotide prodrugs
EP1775630A4 (en) Case
EP1848299A4 (en) Case
ZA200800365B (en) Substituted tetrahydroqulnolines
IL190012A0 (en) Sulphonamide derivatives
ZA200805659B (en) Sulfamoyl sulfonate prodrugs
GB0519825D0 (en) Sealant smoother
ZA200805660B (en) Heteroaromatic sulfonamide prodrugs
GB2433078B (en) Structural member
GB0515699D0 (en) Prodrugs
AU2006283208A8 (en) Sulfonamides
GB0503644D0 (en) Catstep I
PL375476A1 (en) Vectorial thermoanemometer
AU3393P (en) Breakwell xTriticosecale
AU3292P (en) DP303 Dianella prunina
GB0511495D0 (en) Novel structures
GB0515624D0 (en) Breakwaters
GB0515595D0 (en) Azo compounds
GB0515596D0 (en) Azo compounds
GB0515598D0 (en) Azo compounds
GB0515594D0 (en) Azo compounds
GB0515591D0 (en) Azo compounds
GB0515599D0 (en) Azo compounds
GB0501709D0 (en) H/h/t